Negative Pressure Wound Therapy Market to be Worth $4.04 Billion by 2030

Meticulous Research®-a leading global market research company, published a research report titled, 'Negative Pressure Wound Therapy (NPWT) Market by Product (Conventional/Traditional, Single-use, Accessories), Wound Type (Diabetic Foot Ulcer [DFU], Venous Leg Ulcer, Surgical, Burn, Skin Grafts), End User (Hospital, Home Care) - Global Forecast to 2030.'

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5535

According to this latest publication from Meticulous Research®, the negative pressure wound therapy market is projected to reach $4.04 billion by 2030, at a CAGR of 6% from 2023 to 2030. The growth of this market is driven by the increasing prevalence of diabetes and chronic wounds, rising elderly population, favorable reimbursement policies and increasing incidence of obesity and associated comorbidities. In addition, the technological advancements in negative pressure wound therapy devices and emerging economies are expected to provide significant growth opportunities for this market.

However, the high costs of NPWT devices and the potential risk of complications are expected to restrain the growth of this market to a certain extent. In addition, factors such as the limited awareness and training of healthcare professionals and the lack of adherence to the treatment among patients due to discomfort pose major challenges to the market's growth.

Key Players:

The key players operating in the negative pressure wound therapy market are Acelity L.P. Inc. (U.S.), Cardinal Health, Inc. (U.S.), Convatec Group plc (U.S.), DeRoyal Industries, Inc. (U.S.), Genadyne Biotechnologies, Inc. (U.S.), Medela AG (Switzerland), Mölnlycke Health Care AB (Sweden), Smith & Nephew plc (U.K.), PAUL HARTMANN AG (Germany), and Talley Group Ltd (U.K.).

Request Sample Report Pages @ https://www.meticulousresearch.com/request-sample-report/cp_id=5535

Negative Pressure Wound Therapy Market: Future Outlook

The negative pressure wound therapy market is segmented by product, wound type, end user, and geography. The study also evaluates industry competitors and analyzes the country and regional-level markets.

Based on product, in 2023, the conventional/traditional NPWT devices segment is expected to account for the largest share of the negative pressure wound therapy market. The large market share of this segment is attributed to the high demand for conventional NPWT devices for inpatient care, the high prevalence of acute and chronic open wounds, and the increasing number of surgeries globally.

Based on wound type, in 2023, the diabetic foot ulcers segment is expected to account for the largest share of the negative pressure wound therapy market. The large market share of this segment is attributed to the increased prevalence of diabetes and associated diabetic foot ulcers, increased awareness among patients and proven clinical outcomes to treat the condition.

Based on end user, in 2023, the hospital & clinics segment is expected to account for the largest share of the negative pressure wound therapy market. The large market share of this segment is attributed to the increased adoption of NPWT in hospitals, the high awareness about the benefits of therapy among healthcare professionals, and the rising patient population.

Geographic Review:

This research report analyzes the market across major regions and provides a comprehensive analysis of North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of Asia-Pacific), Latin America, and the Middle East & Africa. In 2023, North America is expected to account for the largest share of the negative pressure wound therapy market, followed by Europe and Asia-Pacific. North America's major market share is attributed to the advanced healthcare infrastructure in the region, the presence of key market players, and the high awareness of the benefits of NPWT for chronic wound management.

Read in Detail @ https://www.meticulousresearch.com/product/negative-pressure-wound-therapy-market-5535

Key questions answered in the report:

Which are the high-growth market segments in terms of product, wound type, end user, and region/country?
What was the historical market size for negative pressure wound therapy across the globe?
What are the market forecasts and estimates for the period 2023-2030?
What are the major drivers, restraints, opportunities, and challenges in the global negative pressure wound therapy market?
Who are the major players in the negative pressure wound therapy market?
How is the competitive landscape, and who are the market leaders in the global negative pressure wound therapy market?
What are the recent developments in the global negative pressure wound therapy market?
What are the different strategies adopted by the major players in the global negative pressure wound therapy market?
What are the geographical trends and high-growth regions/countries?

Contact Data
Mr. Khushal Bombe
Meticulous Research®
Direct Lines: +1-646-781-8004 (North America)
+44-203-868-8738 (Europe)
+91 744-7780008 (Asia-Pacific)
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/

Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.

This release was published on openPR.